• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助生殖治疗中卵巢刺激期间的促黄体生成素谱。

Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment.

作者信息

Verschuere Hannah, Laenen Annouschka, Debrock Sophie, Tomassetti Carla, Lie Fong Sharon

机构信息

Leuven University Fertility Center, Department of Gynecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.

Fertility Clinic Brussels, Clinic St. Jean Brussels, Brussels, Belgium.

出版信息

Front Endocrinol (Lausanne). 2024 Dec 4;15:1481546. doi: 10.3389/fendo.2024.1481546. eCollection 2024.

DOI:10.3389/fendo.2024.1481546
PMID:39698040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11652183/
Abstract

INTRODUCTION

Few data is available on the natural course of luteinizing hormone (LH) during ovarian stimulation, but it has been suggested that 'oversuppressed' LH could decrease fertility outcomes. Our aim with this study is to evaluate the changes in LH depending on the used stimulation protocol to better define LH oversuppressioin.

METHODS

Patients undergoing oocyte retrieval in a tertiary fertility center between 01-01-2015 and 30-09-2020 after stimulation with a short-agonist (SA) or antagonist (A) protocol were included. Data were retrospectively retrieved from 858 electronic patient records, of which 338 SA cycles and 783 A cycles. A continuous profile was set out to evaluate the pooled measurements of the mean LH in time during ovarian stimulation and linear mixed modeling was used to compare the change of LH between 4 time points: the day prior to start of gonadotrophins (T1), stimulation day 5 (T2), stimulation day 6 (T3) and on the day of oocyte maturation trigger (T4). Oversuppression of LH was defined as a decrease of LH > 50% after initiation of GnRH antagonist and LH levels < 1.2 IU/l after GnRH antagonist. A subanalysis was performed for type of gonadotrophin (recFSH vs hp-hMG).

RESULTS

In the SA protocol, an initial LH peak was followed by a slow decrease of LH until triggering. In the A protocol, LH decreased after gonadotrophin initiation with a further rapid decrease after initiation of the antagonist and remained low until trigger. LH levels dropped > 50% in 26.2% of the antagonist cycles and LH levels were < 1.2 IU/l in 45.3% of cycles after initiation of GnRH-antagonist.

CONCLUSION

The course of LH in the SA protocol differs from the A protocol where low mean LH levels are seen. Oversuppression of LH, or iatrogenic LH deficiency as described in earlier studies, may be a rather pervasive phenomenon during stimulation with an antagonist protocol and warrants further investigation to elucidate the clinical relevance of low LH levels during ovarian stimulation.

摘要

引言

关于卵巢刺激过程中促黄体生成素(LH)的自然病程,可用数据较少,但有研究表明,“过度抑制”的LH可能会降低生育结局。本研究的目的是评估根据所用刺激方案,LH的变化情况,以更好地界定LH过度抑制。

方法

纳入2015年1月1日至2020年9月30日期间,在一家三级生殖中心接受短方案激动剂(SA)或拮抗剂(A)刺激后进行卵母细胞取卵的患者。数据从858份电子病历中回顾性获取,其中338个SA周期和783个A周期。绘制连续曲线以评估卵巢刺激期间平均LH的汇总测量值,并使用线性混合模型比较4个时间点之间LH的变化:促性腺激素开始使用前一天(T1)、刺激第5天(T2)、刺激第6天(T3)和卵母细胞成熟触发日(T4)。LH过度抑制定义为GnRH拮抗剂开始使用后LH下降>50%,且GnRH拮抗剂使用后LH水平<1.2 IU/L。对促性腺激素类型(重组FSH与高纯度人绝经期促性腺激素)进行了亚组分析。

结果

在SA方案中,最初出现LH峰值,随后LH缓慢下降直至触发。在A方案中,促性腺激素开始使用后LH下降,拮抗剂开始使用后进一步快速下降,并在触发前一直保持低水平。在26.2%的拮抗剂周期中,LH水平下降>50%,在GnRH拮抗剂开始使用后,45.3%的周期中LH水平<1.2 IU/L。

结论

SA方案中LH的变化过程与A方案不同,A方案中LH平均水平较低。LH过度抑制,或如早期研究所描述的医源性LH缺乏,在拮抗剂方案刺激期间可能是一种相当普遍的现象,需要进一步研究以阐明卵巢刺激期间低LH水平的临床相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/2688c2056687/fendo-15-1481546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/0eee36105ec1/fendo-15-1481546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/4b4e4a32c371/fendo-15-1481546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/2688c2056687/fendo-15-1481546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/0eee36105ec1/fendo-15-1481546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/4b4e4a32c371/fendo-15-1481546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/11652183/2688c2056687/fendo-15-1481546-g003.jpg

相似文献

1
Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment.辅助生殖治疗中卵巢刺激期间的促黄体生成素谱。
Front Endocrinol (Lausanne). 2024 Dec 4;15:1481546. doi: 10.3389/fendo.2024.1481546. eCollection 2024.
2
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.通过在卵巢刺激开始时测量血清 LH 预测 GnRH 激动剂触发后卵母细胞产量不佳。
Hum Reprod. 2019 Oct 2;34(10):2027-2035. doi: 10.1093/humrep/dez132.
3
Impact of Luteinizing Hormone on IVF/ICSI Assisted Reproduction on the Initiation Day of Gonadotropin-releasing Hormone Antagonist Protocol.促黄体生成素对促性腺激素释放激素拮抗剂方案启动日IVF/ICSI辅助生殖的影响
Endocr Metab Immune Disord Drug Targets. 2025;25(5):400-410. doi: 10.2174/0118715303281640240722070348.
4
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.重组卵泡刺激素和重组促黄体生成素联合 GnRH 拮抗剂方案与单独使用重组卵泡刺激素方案在年龄≥35 岁患者卵巢刺激中的随机对照研究。
Hum Reprod. 2015 May;30(5):1188-95. doi: 10.1093/humrep/dev038. Epub 2015 Mar 3.
5
Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol.用 GnRH 激动剂触发卵母细胞成熟后循环黄体生成素水平可能预测灵活 GnRH 拮抗剂方案中的卵母细胞产量。
Hum Reprod. 2012 May;27(5):1351-6. doi: 10.1093/humrep/des049. Epub 2012 Mar 14.
6
Predictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation protocols: a retrospective observational cohort study.控制性卵巢刺激方案中卵母细胞取卵失败的预测因素:一项回顾性观察队列研究。
Reprod Biol Endocrinol. 2015 Jun 2;13:53. doi: 10.1186/s12958-015-0052-x.
7
Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.预测促性腺激素释放激素激动剂(GnRHa)触发后卵母细胞成熟的成功诱导。
Hum Reprod. 2013 Jan;28(1):152-9. doi: 10.1093/humrep/des361. Epub 2012 Oct 17.
8
Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.枸橼酸氯米酚在 GnRH 激动剂扳机后对黄体期的影响。
Reprod Biomed Online. 2014 Mar;28(3):359-68. doi: 10.1016/j.rbmo.2013.10.019. Epub 2013 Oct 31.
9
Gonadotrophin-releasing hormone antagonists for assisted conception.用于辅助生殖的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2001(4):CD001750. doi: 10.1002/14651858.CD001750.
10
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.35 岁及以上接受 IVF/ICSI 的女性中,重组 LH 补充到标准 GnRH 拮抗剂方案中:一项随机对照多中心研究。
Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.

引用本文的文献

1
Management of LH/FSH deficiency among assisted reproduction specialists in Spain: a Delphi consensus.西班牙辅助生殖专家对促黄体生成素/促卵泡生成素缺乏症的管理:德尔菲共识
Front Endocrinol (Lausanne). 2025 Aug 5;16:1498062. doi: 10.3389/fendo.2025.1498062. eCollection 2025.

本文引用的文献

1
Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.促性腺激素释放激素拮抗剂方案控制性卵巢刺激中血清 LH 水平低会降低新鲜胚胎移植后的活产率,但在全冷冻周期中无影响。
Front Endocrinol (Lausanne). 2021 Apr 23;12:640047. doi: 10.3389/fendo.2021.640047. eCollection 2021.
2
Reduced FSH and LH action: implications for medically assisted reproduction.降低 FSH 和 LH 的作用:对医学辅助生殖的影响。
Hum Reprod. 2021 May 17;36(6):1469-1480. doi: 10.1093/humrep/deab065.
3
Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.
在固定与灵活使用促性腺激素释放激素拮抗剂方案进行卵巢刺激期间内源性黄体生成素浓度与体外受精结局:一项随机对照试验
Int J Reprod Biomed. 2018 Mar;16(3):175-182.
4
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.辅助生殖技术中重组促黄体生成素的补充:系统评价。
Fertil Steril. 2018 Apr;109(4):644-664. doi: 10.1016/j.fertnstert.2018.01.003.
5
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.重组促黄体生成素(rLH)和重组促卵泡生成素(rFSH)用于体外受精/卵胞浆内单精子注射周期中的卵巢刺激。
Cochrane Database Syst Rev. 2017 May 24;5(5):CD005070. doi: 10.1002/14651858.CD005070.pub3.
6
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2015 Nov 9;2015(11):CD006919. doi: 10.1002/14651858.CD006919.pub4.
7
Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol.从理论到实践的个体化治疗:在基于促性腺激素释放激素拮抗剂的刺激方案中添加促黄体生成素的个案
Clin Med Insights Reprod Health. 2014 Oct 14;8:59-64. doi: 10.4137/CMRH.S17788. eCollection 2014.
8
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.35 岁及以上接受 IVF/ICSI 的女性中,重组 LH 补充到标准 GnRH 拮抗剂方案中:一项随机对照多中心研究。
Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.
9
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.一项比较高纯度 hMG 和重组 FSH 在 GnRH 拮抗剂周期中与强制性单囊胚移植的随机评估员盲法试验。
Fertil Steril. 2012 Mar;97(3):561-71. doi: 10.1016/j.fertnstert.2011.12.016. Epub 2012 Jan 13.
10
Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.内源性黄体生成素血清水平对人绒毛膜促性腺激素注射日孕激素升高的影响。
Fertil Steril. 2011 Sep;96(3):600-4. doi: 10.1016/j.fertnstert.2011.06.061.